The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Prostate Cancer Diagnosis and Treatment Market Research Report 2024

Global Prostate Cancer Diagnosis and Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1893132

No of Pages : 103

Ask Your Query
Synopsis
The global Prostate Cancer Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostate Cancer Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Cancer Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Cancer Diagnosis and Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Cancer Diagnosis and Treatment include Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnosis and Treatment.
Report Scope
The Prostate Cancer Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
AbbVie
Active Biotech
Amgen
Astellas Pharma
AstraZeneca
Bavarian Nordic
Bayer
Bristol-Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen
Johnson & Johnson
Pfizer
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals
Segment by Type
Prostate Specific Antigen Test (PSA)
Digital Rectal Exam (DRE)
Segment by Application
Hospitals
Diagnostic clinics
Research centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnosis and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prostate Specific Antigen Test (PSA)
1.2.3 Digital Rectal Exam (DRE)
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2019-2030)
2.2 Prostate Cancer Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Diagnosis and Treatment Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Treatment Industry Trends
2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers
2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges
2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2023
3.5 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2019-2030)
6.2 North America Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2019-2030)
7.2 Europe Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2019-2030)
9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.2.5 AbbVie Recent Development
11.3 Active Biotech
11.3.1 Active Biotech Company Detail
11.3.2 Active Biotech Business Overview
11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.3.5 Active Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.4.5 Amgen Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Detail
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.5.5 Astellas Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Detail
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.7.5 Bavarian Nordic Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Dendreon
11.10.1 Dendreon Company Detail
11.10.2 Dendreon Business Overview
11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.10.5 Dendreon Recent Development
11.11 Endo
11.11.1 Endo Company Detail
11.11.2 Endo Business Overview
11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.11.5 Endo Recent Development
11.12 Ferring Pharmaceuticals
11.12.1 Ferring Pharmaceuticals Company Detail
11.12.2 Ferring Pharmaceuticals Business Overview
11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.12.5 Ferring Pharmaceuticals Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Detail
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.13.5 GE Healthcare Recent Development
11.14 GSK
11.14.1 GSK Company Detail
11.14.2 GSK Business Overview
11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.14.5 GSK Recent Development
11.15 Ipsen
11.15.1 Ipsen Company Detail
11.15.2 Ipsen Business Overview
11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.15.5 Ipsen Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Detail
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.16.5 Johnson & Johnson Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Detail
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.17.5 Pfizer Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Detail
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.18.5 Sanofi Recent Development
11.19 Siemens Healthineers
11.19.1 Siemens Healthineers Company Detail
11.19.2 Siemens Healthineers Business Overview
11.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
11.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.19.5 Siemens Healthineers Recent Development
11.20 Takeda
11.20.1 Takeda Company Detail
11.20.2 Takeda Business Overview
11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.20.5 Takeda Recent Development
11.21 Teva Pharmaceutical
11.21.1 Teva Pharmaceutical Company Detail
11.21.2 Teva Pharmaceutical Business Overview
11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.21.5 Teva Pharmaceutical Recent Development
11.22 Tolmar Pharmaceuticals
11.22.1 Tolmar Pharmaceuticals Company Detail
11.22.2 Tolmar Pharmaceuticals Business Overview
11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2019-2024)
11.22.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock